The role of ferritin in liver disease assessment
Background. Ferritin is an important integral and diagnostic marker of liver diseases. In 1/3 of patients with nonalcoholic fatty liver disease (NAFLD), manifestations of hyperferritinemia are revealed. Increased ferritin level indicates the severity of the disease course and affects the prognosis.O...
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
IRBIS LLC
2023-11-01
|
| Series: | Фармакоэкономика |
| Subjects: | |
| Online Access: | https://www.pharmacoeconomics.ru/jour/article/view/895 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849696828156542976 |
|---|---|
| author | V. G. Radchenko V. B. Grinevich E. S. Ivanyuk L. B. Lazebnik |
| author_facet | V. G. Radchenko V. B. Grinevich E. S. Ivanyuk L. B. Lazebnik |
| author_sort | V. G. Radchenko |
| collection | DOAJ |
| description | Background. Ferritin is an important integral and diagnostic marker of liver diseases. In 1/3 of patients with nonalcoholic fatty liver disease (NAFLD), manifestations of hyperferritinemia are revealed. Increased ferritin level indicates the severity of the disease course and affects the prognosis.Objective: to determine the prevalence and character of hyperferritinemia manifestations in NAFLD patients and to evaluate the effectiveness of its correction with human placenta hydrolysate.Material and methods. We examined 158 patients aged from 20 to 63 years (92 men and 66 women). There were no significant differences in age between men and women. The control group consisted of 20 practically healthy individuals. Molecular mechanisms of peptide components of human placenta hydrolysate (Laennec®) impact on pathophysiological processes of serum ferritin disorders, iron metabolism indicators, and inflammation manifestations were analyzed.Results. Nineteen peptides potentially important for regulation of iron homeostasis were identified in Laennec® composition. These peptides contribute to the elimination of iron metabolism disorders by regulating the levels of hepcidin (the main hormone of iron homeostasis), reducing ferritin synthesis, as well as exhibiting anti-inflammatory, and immunomodulatory effects. The efficacy of the drug monotherapy in patients with hyperferritinemia was shown.Conclusion. Laennec® was found to be one of the medicines contributing to the reduction of hyperferritinemia manifestations, iron metabolism disorders, and systemic inflammatory process in NAFLD. |
| format | Article |
| id | doaj-art-e714a9a9983e41a8963c02e6cec3589e |
| institution | DOAJ |
| issn | 2070-4909 2070-4933 |
| language | Russian |
| publishDate | 2023-11-01 |
| publisher | IRBIS LLC |
| record_format | Article |
| series | Фармакоэкономика |
| spelling | doaj-art-e714a9a9983e41a8963c02e6cec3589e2025-08-20T03:19:20ZrusIRBIS LLCФармакоэкономика2070-49092070-49332023-11-0116343244610.17749/2070-4909/farmakoekonomika.2023.200458The role of ferritin in liver disease assessmentV. G. Radchenko0V. B. Grinevich1E. S. Ivanyuk2L. B. Lazebnik3Kirov Military Medical AcademyYevdokimov Moscow State University of Medicine and DentistryYevdokimov Moscow State University of Medicine and DentistryYevdokimov Moscow State University of Medicine and DentistryBackground. Ferritin is an important integral and diagnostic marker of liver diseases. In 1/3 of patients with nonalcoholic fatty liver disease (NAFLD), manifestations of hyperferritinemia are revealed. Increased ferritin level indicates the severity of the disease course and affects the prognosis.Objective: to determine the prevalence and character of hyperferritinemia manifestations in NAFLD patients and to evaluate the effectiveness of its correction with human placenta hydrolysate.Material and methods. We examined 158 patients aged from 20 to 63 years (92 men and 66 women). There were no significant differences in age between men and women. The control group consisted of 20 practically healthy individuals. Molecular mechanisms of peptide components of human placenta hydrolysate (Laennec®) impact on pathophysiological processes of serum ferritin disorders, iron metabolism indicators, and inflammation manifestations were analyzed.Results. Nineteen peptides potentially important for regulation of iron homeostasis were identified in Laennec® composition. These peptides contribute to the elimination of iron metabolism disorders by regulating the levels of hepcidin (the main hormone of iron homeostasis), reducing ferritin synthesis, as well as exhibiting anti-inflammatory, and immunomodulatory effects. The efficacy of the drug monotherapy in patients with hyperferritinemia was shown.Conclusion. Laennec® was found to be one of the medicines contributing to the reduction of hyperferritinemia manifestations, iron metabolism disorders, and systemic inflammatory process in NAFLD.https://www.pharmacoeconomics.ru/jour/article/view/895nonalcoholic fatty liver diseasenafldferritiniron metabolism disordersystemic inflammationinsulin resistancehuman placenta hydrolysate peptideslaennec |
| spellingShingle | V. G. Radchenko V. B. Grinevich E. S. Ivanyuk L. B. Lazebnik The role of ferritin in liver disease assessment Фармакоэкономика nonalcoholic fatty liver disease nafld ferritin iron metabolism disorder systemic inflammation insulin resistance human placenta hydrolysate peptides laennec |
| title | The role of ferritin in liver disease assessment |
| title_full | The role of ferritin in liver disease assessment |
| title_fullStr | The role of ferritin in liver disease assessment |
| title_full_unstemmed | The role of ferritin in liver disease assessment |
| title_short | The role of ferritin in liver disease assessment |
| title_sort | role of ferritin in liver disease assessment |
| topic | nonalcoholic fatty liver disease nafld ferritin iron metabolism disorder systemic inflammation insulin resistance human placenta hydrolysate peptides laennec |
| url | https://www.pharmacoeconomics.ru/jour/article/view/895 |
| work_keys_str_mv | AT vgradchenko theroleofferritininliverdiseaseassessment AT vbgrinevich theroleofferritininliverdiseaseassessment AT esivanyuk theroleofferritininliverdiseaseassessment AT lblazebnik theroleofferritininliverdiseaseassessment AT vgradchenko roleofferritininliverdiseaseassessment AT vbgrinevich roleofferritininliverdiseaseassessment AT esivanyuk roleofferritininliverdiseaseassessment AT lblazebnik roleofferritininliverdiseaseassessment |